Elesta announces that the Chinese regulatory authority National Medical Products Administration (NMPA) has approved EchoLaser for use in prostatic diseases. This approval is a major achievement and represents a great opportunity for Elesta (distributed in China by... Leggi tutto
New office dedicated to the EchoLaser in Cisanello, Pisa
Exciting News in Medical Innovation! We are thrilled to share that the Azienda Ospedaliero-Universitaria Pisana Ospedale Cisanello has recently introduced groundbreaking minimally invasive procedures for thyroid and prostate treatments, utilizing EchoLaser TPLA... Leggi tutto
EchoLaser for Thyroid
The advantages of EchoLaser for the thermoablation of thyroid nodules are clear and obvious. This explains DR. Fedele Antonio De Marino, Expert in the field. Contact us to learn more : info@elesta-echolaser.com... Leggi tutto
EchoLaser on Corriere della Sera
Elesta EchoLaser has been featured on Corriere della Sera, number one newspaper in Italy by circulation and readership. Its urology application for the treatment of BPH symptoms is TPLA (transperineal laser ablation), aka SoracteLite. It is a novel technique which is... Leggi tutto
Practical Theoretical Course at the LXY Institute in MADRID!
The theoretical – practical course at the LXY Institute in Madrid, where EchoLaser TPLA played a central role as a treatment for IPB, ended. Discover more thanks to Dr. Pablo Garrido Abad! III Edición Curso Práctico en STUI y Patología Vesicoprostática basado en... Leggi tutto
EchoLaser: the first choice
The echolaser phenomenon for the treatment of benign prostatic hyperplasia is spreading without limits. TPLA is increasingly being used among professionals with enormous satisfaction. Is the turn of the hospital paolo borsellino of Marsala with Dr. Emanuele Caldarera... Leggi tutto
This site uses cookies to provide you with a better browsing experience. By accepting this banner, scrolling down this page, clicking on a link or continuing to browse in any other way, you consent to the use of cookies. If want to know more read our cookie policy. AcceptRead the policy
